Published 1989 | Version v1.0.0
Journal Article Open

Adrenoleukodystrophy

Abstract

The biochemical and clinical efficacy of dietary erucic acid (C22:1) therapy for X-l inked adrenoleukodystrophy (ALD) was investigated at the Departments of Pediatrics, Human Genetics, Neurology, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA, and the Department of Neurology, University of California, Davis, Sacramento, CA.

Files

PNB-3-89.pdf

Files (2.2 MB)

Name Size Download all
md5:4f809b9efffc655a24533d7fbc405efa
2.2 MB Preview Download

Additional details

Identifiers

Other
PNB-3-89

Dates

Created
1989
When the item was originally created.